Krengli Marco, Ballarè Andrea, Cannillo Barbara, Rudoni Marco, Kocjancic Ervin, Loi Gianfranco, Brambilla Marco, Inglese Eugenio, Frea Bruno
Department of Radiotherapy, University of Piemonte Orientale, Novara, Italy.
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1100-4. doi: 10.1016/j.ijrobp.2006.06.047. Epub 2006 Sep 11.
This study aims to investigate the in vivo drainage of lymphatic spread by using the sentinel node (SN) technique and single-photon emission computed tomography (SPECT)-computed tomography (CT) image fusion, and to analyze the impact of such information on conformal pelvic irradiation.
Twenty-three prostate cancer patients, candidates for radical prostatectomy already included in a trial studying the SN technique, were enrolled. CT and SPECT images were obtained after intraprostate injection of 115 MBq of 99mTc-nanocolloid, allowing identification of SN and other pelvic lymph nodes. Target and nontarget structures, including lymph nodes identified by SPECT, were drawn on SPECT-CT fusion images. A three-dimensional conformal treatment plan was performed for each patient.
Single-photon emission computed tomography lymph nodal uptake was detected in 20 of 23 cases (87%). The SN was inside the pelvic clinical target volume (CTV2) in 16 of 20 cases (80%) and received no less than the prescribed dose in 17 of 20 cases (85%). The most frequent locations of SN outside the CTV2 were the common iliac and presacral lymph nodes. Sixteen of the 32 other lymph nodes (50%) identified by SPECT were found outside the CTV2. Overall, the SN and other intrapelvic lymph nodes identified by SPECT were not included in the CTV2 in 5 of 20 (25%) patients.
The study of lymphatic drainage can contribute to a better knowledge of the in vivo potential pattern of lymph node metastasis in prostate cancer and can lead to a modification of treatment volume with consequent optimization of pelvic irradiation.
本研究旨在利用前哨淋巴结(SN)技术和单光子发射计算机断层扫描(SPECT)-计算机断层扫描(CT)图像融合技术,研究淋巴转移的体内引流情况,并分析此类信息对盆腔适形放疗的影响。
招募了23例前列腺癌患者,这些患者均为已纳入一项研究SN技术的试验中的前列腺癌根治术候选人。在前列腺内注射115MBq的99mTc-纳米胶体后,获取CT和SPECT图像,以识别SN和其他盆腔淋巴结。在SPECT-CT融合图像上描绘包括SPECT识别出的淋巴结在内的靶区和非靶区结构。为每位患者制定三维适形治疗计划。
23例中有20例(87%)检测到单光子发射计算机断层扫描淋巴结摄取。20例中有16例(80%)的SN位于盆腔临床靶区(CTV2)内,20例中有17例(85%)接受的剂量不少于规定剂量。CTV2外SN最常见的位置是髂总淋巴结和骶前淋巴结。SPECT识别出的32个其他淋巴结中有16个(50%)位于CTV2外。总体而言,20例患者中有5例(25%)的SPECT识别出的SN和其他盆腔内淋巴结未包含在CTV2内。
淋巴引流研究有助于更好地了解前列腺癌淋巴结转移的体内潜在模式,并可导致治疗体积的改变,从而优化盆腔放疗。